HRT FINANCIAL LP

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1475597 NEW YORK, NY

Position in MDGL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$45,444,226

+$42,987,916 QoQ

Shares Held

84,634

+1906.5% QoQ

Ownership

0.366%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#49

of 402 holders

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $848,593,086 across 183 Biotechnology names. MDGL ranks #4 (5.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc. This page	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc.	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$45,444,226	84,634	+1906.5%	Shares	Defined	2026-08-14
2025-12-31	$2,456,310	4,218	-66.5%	Shares	Defined	2026-02-12
2024-12-31	$3,884,279	12,588	+24.8%	Shares	Defined	2025-02-14
2024-09-30	$2,140,875	10,088	+171.5%	Shares	Defined	2024-11-12
2023-12-31	$859,808	3,716	-72.0%	Shares	Defined	2024-02-09
2023-03-31	$3,214,790	13,270	+21.5%	Shares	Defined	2023-05-12
2022-12-31	$3,169,239	10,919	+13.9%	Shares	Defined	2023-02-10
2021-12-31	$812,571	9,589	-10.9%	Shares	Defined	2022-02-14
2021-06-30	$1,048,034	10,759	+53.3%	Shares	Defined	2021-08-16
2020-09-30	$833,365	7,019	—	Shares	Defined	2020-11-13
No filing history on record for this holder in this stock.